 Home > Drugs > Gemcitabine Hydrochloride

Gemcitabine Hydrochloride

Indication

Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Bladder cancer Pancreatic cancer Small cell lung cancer Lung cancer Breast cancer

Packaging Specification

－－－－

Manufacturer

Lianyungang JARI Pharmaceutical Co., Ltd.

Founded in:

2004-07-20
Address:

No. 18 Zhenhua Road, Lianyungang City
Tax NO.:

913207007635748894
Registered Funds:

100 million yuan
Email:

Log in to view

Other Drugs of Lianyungang JARI Pharmaceutical Co., Ltd.

Gemcitabine Hydrochloride Gemcitabine Hydrochloride for Injection Irinotecan hydrochloride Decitabine for injection Decitabine Oxaliplatin



Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)

National-level Technology-based SME
China's Top 100 Industrial Digitalization Enterprises List
The Drafting Unit of the "Specification for Operation and Management of Self-build Cross-border E-commerce Website" of the CCPIT
High-Tech Enterprise

鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Digital Technology Co., Ltd.



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.